5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice
- 6 November 2002
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 28 (5), 850-856
- https://doi.org/10.1038/sj.npp.1300109
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Neurobiological bases for the relation between sleep and depressionSleep Medicine Reviews, 2002
- The role of 5‐HT1B receptors in the regulation of serotonin cell firing and release in the rat brainJournal of Neurochemistry, 2001
- Regional changes in density of serotonin transporter in the brain of 5‐HT1A and 5‐HT1B knockout mice, and of serotonin innervation in the 5‐HT1B knockoutJournal of Neurochemistry, 2001
- How does pindolol improve antidepressant action?Trends in Pharmacological Sciences, 2001
- Potentiation of the antinociceptive effect of clomipramine by a 5‐ht1A antagonist in neuropathic pain in ratsBritish Journal of Pharmacology, 2001
- A review of central 5-HT receptors and their functionNeuropharmacology, 1999
- Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in ratsBrain Research, 1997
- Effects of the selective 5‐HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in ratsJournal of Sleep Research, 1994
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- The 5-HT1A antagonist (−)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in ratsPharmacology Biochemistry and Behavior, 1992